172@29@17@104!~!172@29@0@53!~!|news|india|india-coronavirus-update-covid-19-caseload-races-past-62-lakh-death-toll-nears-1-lakh-5903321.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Watch experts decode 'The rise of ESG investing' on October 29 at 4pm. Register Now!
you are here: HomeNewsIndia
Last Updated : Sep 30, 2020 10:10 AM IST | Source: PTI

India coronavirus update: COVID-19 caseload races past 62 lakh, death toll nears 1 lakh

The total number of coronavirus cases mounted to 62,25,763, while the death toll climbed to 97,497 with 1,179 people succumbing to the disease in a day, the data updated at 8 am showed.

PTI

India's COVID-19 caseload raced past 62 lakh on Wednesday with 80,472 infections being reported in a day, while the number of recoveries surged to 51,87,825 pushing the recovery rate to 83.33 percent, according to the Union Health Ministry data.

The total number of coronavirus cases mounted to 62,25,763, while the death toll climbed to 97,497 with 1,179 people succumbing to the disease in a day, the data updated at 8 am showed.

There are 9,40,441 active cases of coronavirus infection in the country which comprises 15.11 percent of the total caseload. The COVID-19 case fatality rate due to the coronavirus infection stands at 1.57 percent, the data stated.

Close

India's COVID-19 tally had crossed the 20-lakh mark on August 7, on August 23 it crossed 30 lakh, and 40 lakh on September 5. The tally went past 50 lakh on September 16 and crossed 60 lakh on September 28.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
According to the Indian Council of Medical Research (ICMR), cumulatively 7,41,96,729 samples have been tested for detection of coronavirus infection up to September 29 with 10,86,688 samples being tested on Tuesday.
First Published on Sep 30, 2020 10:05 am
Sections